Live Breaking News & Updates on Li Lilly Antibody Cocktail

Stay updated with breaking news from Li lilly antibody cocktail. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Eli Lilly's antibody cocktail gets DCGI nod to treat moderate Covid


Eli Lilly and Company India on Tuesday said it has received permission for emergency use of its antibody drugs combination used for treatment of mild to moderate Covid-19, in the country.
The company has received permission for restricted emergency use of its monoclonal antibody drugs, bamlanivimab 700 mg and etesevimab 1400 mg, used together for the treatment of patients with mild to moderate Covid-19, Eli Lilly said in a statement.
Lilly is engaging in active dialogue with the Indian government and regulatory authorities to donate bamlanivimab and etesevimab in order to speed up access and provide treatment options for patients with Covid-19, it added. ....

Eli Lilly , Company India Md Luca Visini , Company India On , Company India , Emergency Use Authorisation , Coronavirus Drugs , Eli Lilly , Li Lilly Drugs , Li Lilly Antibody Cocktail , Li Lilly Dcgi Nod , எலி லில்லி , நிறுவனம் இந்தியா ,